Cardiff Oncology, Inc. - COM (CRDF)

Historical Portfolio Holders from Q2 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
12.5M
Holdings value Q3 2024
$33.4M
Value change Q3 2024
-$787K
Grand Portfolio weight change Q3 2024
0%
Number of holders
81
Number of buys Q3 2024
32
Number of sells Q3 2024
-37
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 12.5M $33.4M -$787K $2.67 82
2024 Q2 12.8M $28.4M +$5.43M $2.22 89
2024 Q1 8.34M $44.5M +$16.7M $5.34 74
2023 Q4 5.29M $7.84M -$215K $1.48 54
2023 Q3 5.46M $7.58M -$757K $1.39 57
2023 Q2 5.99M $8.81M -$1.67M $1.47 50
2023 Q1 7.05M $11.6M -$749K $1.65 52
2022 Q4 7.7M $10.8M -$190K $1.40 55
2022 Q3 7.92M $12.2M -$1.96M $1.54 49
2022 Q2 8.93M $19.6M -$17.8M $2.20 55
2022 Q1 16.5M $41M -$30.2M $2.48 82
2021 Q4 22M $132M +$5.19M $6.01 82
2021 Q3 21.1M $141M -$36M $6.66 83
2021 Q2 26.5M $176M +$10.8M $6.65 82
2021 Q1 24.1M $223M -$69.8M $9.26 71
2020 Q4 26.6M $479M +$144M $17.99 81
2020 Q3 18.7M $266M +$208M $14.19 66
2020 Q2 4.92M $24.7M +$24.7M $5.01 22